Dr. Riam Shammaa, MD, is the founder of the Canadian Centres for Regenerative Therapy (CCRT), the first recognized private cell therapy centres in Canada.
Dr. Shammaa is also a co-founder of Freyja Therapeutics. A clinical–stage company with a platform based on umbilical cord stem cells for the treatment of inflammatory diseases. He is an active member of board of directors of multiple biotechnology companies.
Dr. Shammaa is a pioneer scientist in regenerative and translational medicine and holds multiple patents in the field. He conducted the first successful spinal discs repair using stem cells in Canada. He also pioneered non-surgical hip and knee repairs for avascular necrosis using stem cell transplants. Dr. Shammaa is the managing director of Regen Capital, with an investment portfolio in biotech, healthcare, fintech and technology. He is also an active member of Maple Leaf Angels.
Dr. Shammaa worked in research at McGill University and in the private sector before completing his residency in family medicine at McGill University. He went on to complete a fellowship in Sports medicine at the University of Toronto. He is a national expert in regenerative and translational medicine. He is also a lecturer at the University of Toronto on Musculoskeletal diseases.